Text Size

A Network Intervention for Prevention of HIV Infection in Chennai, India - 1

This study has been completed.
Sponsor:
Collaborator:
Johns Hopkins University
Information provided by:
Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov Identifier:
NCT00218686
First received: September 16, 2005
Last updated: March 7, 2011
Last verified: March 2011
History of Changes
  Purpose

The purpose of this study is to evaluate a peer-based HIV prevention intervention that targets active injection drug users and their drug and sex partners in Chennai India.


Condition Intervention Phase
HIV Infections
 Behavioral: psychoeducational
Behavioral: control
 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
Official Title: Supplement to the Long-term Impact of a Network Outreach Intervention

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Further study details as provided by Johns Hopkins Bloomberg School of Public Health:

Primary Outcome Measures:
  • needle sharing [ Time Frame: 3 month ] [ Designated as safety issue: No ]
  • condom use [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 400
Study Start Date: January 2003
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
behavioral
 Behavioral: psychoeducational
psychoeducational
Active Comparator: 2
VCT
 Behavioral: control
VTC

Detailed Description:

The intervention to be tested in this study draws upon theoretical and empirical evidence suggesting that peer educator programs can have significant effects on the risk-related behaviors of both the educators and the peers whom they educate. Specifically, through group and individual focused sessions, participants learn and practice skills designed to reduce drug and sex related risk behaviors. Furthermore, individuals and their main risk partners attend a training session that focuses on risk reduction within their relationship.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • drug users
  • network members
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00218686

Locations
India
YRG Care
Chennai, Tamil Nadu, India, 600 113
Sponsors and Collaborators
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University
Investigators
Principal Investigator: Carl Latkin, Ph.D. Johns Hopkins University
  More Information

No publications provided

Responsible Party: Carl Latkin, JHU
ClinicalTrials.gov Identifier: NCT00218686     History of Changes
Other Study ID Numbers: DESPR DA013142, R01-13142-1, NIDA-13142-1
Study First Received: September 16, 2005
Last Updated: March 7, 2011
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
 Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Slow Virus Diseases

ClinicalTrials.gov processed this record on June 13, 2013